TXG (STOCKS)
10x Genomics, Inc. Class A Common Stock
$56.090000
-2.060000 (-3.54%)
Prev close: $58.150000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Serge Saxonov
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $7,308.03M
- Employees
- 1,306
- P/E (TTM)
- -98.61
- P/B (TTM)
- 9.11
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $616.91M |
| Benefits Costs and Expenses | $691.80M |
| Cost Of Revenue | $184.88M |
| Costs And Expenses | $691.80M |
| Gross Profit | $432.03M |
| Nonoperating Income/Loss | $13.49M |
| Operating Expenses | $520.41M |
| Selling, General, and Administrative Expenses | $297.01M |
| Other Operating Expenses | $223.40M |
| Operating Income/Loss | -$88.38M |
| Income/Loss From Continuing Operations After Tax | -$75.13M |
| Income/Loss From Continuing Operations Before Tax | -$74.89M |
| Income Tax Expense/Benefit | $235.00K |
| Income Tax Expense/Benefit, Deferred | -$1.74M |
| Net Income/Loss | -$75.13M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$75.13M |
| Net Income/Loss Available To Common Stockholders, Basic | -$75.13M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.59 |
| Diluted Earnings Per Share | -$0.59 |
| Basic Average Shares | 255,337,283 |
| Diluted Average Shares | 255,337,283 |
| Assets | $1.03B |
| Current Assets | $674.67M |
| Inventory | $52.62M |
| Other Current Assets | $622.06M |
| Noncurrent Assets | $355.40M |
| Fixed Assets | $215.32M |
| Intangible Assets | $61.16M |
| Other Non-current Assets | $78.91M |
| Liabilities | $204.52M |
| Current Liabilities | $118.51M |
| Accounts Payable | $20.69M |
| Wages | $24.74M |
| Other Current Liabilities | $73.07M |
| Noncurrent Liabilities | $86.01M |
| Equity | $825.55M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $825.55M |
| Liabilities And Equity | $1.03B |
| Net Cash Flow From Operating Activities | $127.09M |
| Net Cash Flow From Operating Activities, Continuing | $127.09M |
| Net Cash Flow From Investing Activities | -$19.65M |
| Net Cash Flow From Investing Activities, Continuing | -$19.65M |
| Net Cash Flow From Financing Activities | -$2.54M |
| Net Cash Flow From Financing Activities, Continuing | -$2.54M |
| Exchange Gains/Losses | -$91.00K |
| Net Cash Flow | $104.80M |
| Net Cash Flow, Continuing | $104.89M |
| Comprehensive Income/Loss | -$75.27M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$75.27M |
| Other Comprehensive Income/Loss | -$75.27M |
| Other Comprehensive Income/Loss Attributable To Parent | -$143.00K |